Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.
Maire V, Némati F, Richardson M, Vincent-Salomon A, Tesson B, Rigaill G, Gravier E, Marty-Prouvost B, De Koning L, Lang G, Gentien D, Dumont A, Barillot E, Marangoni E, Decaudin D, Roman-Roman S, Pierré A, Cruzalegui F, Depil S, Tucker GC, Dubois T. Maire V, et al. Among authors: nemati f. Cancer Res. 2013 Jan 15;73(2):813-23. doi: 10.1158/0008-5472.CAN-12-2633. Epub 2012 Nov 9. Cancer Res. 2013. PMID: 23144294
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.
Decaudin D, Vantelon JM, Bourhis JH, Farace F, Bonnet ML, Guillier M, Greissenger N, Marracho MC, Assari S, Bennaceur AL, Némati F, Michon J, Turhan AG, Boccaccio C. Decaudin D, et al. Among authors: nemati f. Bone Marrow Transplant. 2004 Dec;34(12):1089-93. doi: 10.1038/sj.bmt.1704675. Bone Marrow Transplant. 2004. PMID: 15489877 Clinical Trial.
High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.
Decaudin D, Marszak FB, Couturier J, Mathiot C, Martin A, Némati F, Lantz O, Santo Jd, Arnaud P, Bordier V, Vincent-Salomon A, Poupon MF. Decaudin D, et al. Among authors: nemati f. Anticancer Drugs. 2006 Jul;17(6):685-95. doi: 10.1097/01.cad.0000215061.78189.4e. Anticancer Drugs. 2006. PMID: 16917214
Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors.
Meunier J, Lumbroso-Le Rouïc L, Dendale R, Vincent-Salomon A, Asselain B, Arnaud P, Némati F, Fourquet A, Desjardins L, Plancher C, Levy C, Chaoui D, Validire P, Decaudin D. Meunier J, et al. Among authors: nemati f. Leuk Lymphoma. 2006 Jul;47(7):1295-305. doi: 10.1080/10428190500518966. Leuk Lymphoma. 2006. PMID: 16923560
In vivo tumor targeting by the B-subunit of shiga toxin.
Viel T, Dransart E, Nemati F, Henry E, Thézé B, Decaudin D, Lewandowski D, Boisgard R, Johannes L, Tavitian B. Viel T, et al. Among authors: nemati f. Mol Imaging. 2008 Nov-Dec;7(6):239-47. Mol Imaging. 2008. PMID: 19123994
153 results